Ivacaftor and lumacaftor and Novoeight recombinant

• Generic Name: ivacaftor / lumacaftor
• Dosage Forms: n.a.
• Other Brand Names: Orkambi

Ivacaftor and lumacaftor is used to treat cystic fibrosis in adults and children who are at least 2 years old.

Ivacaftor and lumacaftor is for use only in patients with a specific gene mutation related to cystic fibrosis. Before you take ivacaftor and lumacaftor, you may need a medical test to make sure you have this gene mutation.

Ivacaftor and lumacaftor may also be used for purposes not listed in this medication guide.

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur

Novoeight is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Recombinant this medicine works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Recombinant Novoeight is used to treat or prevent bleeding episodes in adults and children with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage.

Recombinant Novoeight is not for use in people with von Willebrand disease.

Recombinant Novoeight may also be used for purposes not listed in this medication guide.